Devices › Device types
FDA product code MRU · class f · Unknown
Implanted subcortical electrical stimulator (motor disorders): medical device reports filed with FDA
2,925 reports carry this product code, 2001–2026; 8 brands with a page.
- 2,925
- reports with this product code
- 0% of all MAUDE reports
- 217
- reports, 12 months to August 2026
- 201 in the 12 months before
- 53.8%
- classified as malfunction
- 62.3% across all reports
- 0.5%
- classified as death, as reported
- 0.9% across all reports
Product code MRU is FDA's classification for "Implanted subcortical electrical stimulator (motor disorders)" (unknown panel), a class f device. 2,925 medical device reports carry this product code, 0% of the MAUDE database, from November 2001 to August 2026.
217 reports arrived in the 12 months to August 2026, close to the 201 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (53.8%), injury (45.6%) and death (0.5%). 8 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Activa | 1,981 | 1,112 | 0.6% | 60.8% |
| Percept | 186 | 1,239 | 0.3% | 58.6% |
| Soletra | 154 | 12 | 4.2% | 48% |
| Unknown Implantable Neurostimulator | 96 | 0 | 2.2% | 29.3% |
| Kinetra | 71 | 1 | 2.1% | 37.3% |
| Implantable Neurostimulator | 50 | 692 | 0.3% | 63.6% |
| Restore | 5 | 27 | 0.1% | 49.4% |
| Unknown Deep Brain Stimulator | 1 | 0 | 4.9% | 17.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Medtronic Neuromodulation | 633 | 21.6% |
| Medtronic Med Rel Medtronic Puerto Rico | 559 | 19.1% |
| Neuro - Villalba | 34 | 1.2% |
| Ipg Mfg Switzerland | 21 | 0.7% |
| Mdt Puerto Rico Operations | 7 | 0.2% |
| Medtronic Europe Sarl | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| High impedance | 407 | 13.9% |
| Battery problema problem with the battery | 317 | 10.8% |
| Failure to deliver energy | 296 | 10.1% |
| Charging problem | 284 | 9.7% |
| Device operates differently than expectedthe device behaved unexpectedly | 274 | 9.4% |
| Connection problema connection problem | 265 | 9.1% |
| Material integrity problema problem with the device material | 228 | 7.8% |
| Communication or transmission problemthe device could not communicate or transmit | 184 | 6.3% |
| Breakthe device broke | 175 | 6% |
| Insufficient device problem information | 167 | 5.7% |
| Low impedance | 154 | 5.3% |
| Migration or expulsion of device | 147 | 5% |
| Inappropriate/inadequate shock/stimulation | 125 | 4.3% |
| Malposition of device | 110 | 3.8% |
| Device displays incorrect message | 103 | 3.5% |
| Impedance problem | 97 | 3.3% |
| Improper or incorrect procedure or method | 93 | 3.2% |
| Electromagnetic compatibility problem | 87 | 3% |
| Low battery | 80 | 2.7% |
| Premature discharge of battery | 70 | 2.4% |
Questions about implanted subcortical electrical stimulator (motor disorders) reports
What is product code MRU?
FDA's classification code for "Implanted subcortical electrical stimulator (motor disorders)", class f, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,925 reports through August 2026, 217 of them in the latest 12 months.
Which brands appear most often?
Activa (1,981), Percept (186), Soletra (154), Unknown Implantable Neurostimulator (96) and Kinetra (71). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.